Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Nussinov Website

Ruth Nussinov, Ph.D.

Selected Publications

1)  Nussinov R, Tsai CJ, Mattos C.
"Pathway drug cocktail": targeting Ras signaling based on structural pathways.
Trends Mol Med. 19: 695-704, 2013.
2)  Tsai CJ, Nussinov R.
The molecular basis of targeting protein kinases in cancer therapeutics.
Semin. Cancer Biol. 23: 235-42, 2013.
3)  Nussinov R, Tsai CJ.
Allostery in disease and in drug discovery.
Cell. 153: 293-305, 2013.
4)  Nussinov R, Tsai CJ, Ma B.
The underappreciated role of allostery in the cellular network.
Annu Rev Biophys. 42: 169-89, 2013.
5)  Nussinov R.
The spatial structure of cell signaling systems.
Phys Biol. 10: 045004, 2013.
6)  Huang Q, Yu L, Levine AJ, Nussinov R, Ma B.
Dipeptide analysis of p53 mutations and evolution of p53 family proteins.
Biochim. Biophys. Acta. 1844: 198-206, 2014.
7)  Nussinov R, Ma B, Tsai C.
A broad view of scaffolding suggests that scaffolding proteins can actively control regulation and signaling of multienzyme complexes through allostery.
Biochim. Biophys. Acta. 1834: 820-9, 2013.
8)  Szilagyi A, Nussinov R, Csermely P.
Allo-network drugs: extension of the allosteric drug concept to protein- protein interaction and signaling networks.
Curr Top Med Chem. 13: 64-77, 2013.
9)  Nussinov R, Ma B, Tsai CJ, Csermely P.
Allosteric conformational barcodes direct signaling in the cell.
Structure. 21: 1509-21, 2013.
10)  Jang H, Connelly L, Arce FT, Ramachandran S, Lal R, Kagan BL, Nussinov R.
Alzheimer"s disease: which type of amyloid-preventing drug agents to employ?.
Phys Chem Chem Phys. 15: 8868-77, 2013.
Click Here to View Expanded Bibliography.

This page was last updated on 12/11/2013.